Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells.
about
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytesHepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCVAberrant receptor-mediated endocytosis of Schistosoma mansoni glycoproteins on host lipoproteinsSelf-adjuvanting C18 lipid vinil sulfone-PP2A vaccine: study of the induced immunomodulation against Trichuris muris infectionIdentification of new cytotoxic T-cell epitopes on the 38-kilodalton lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptides.A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.A subdominant CD8(+) cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture.Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.Defined synthetic vaccines.Vaccination with lipid core peptides fails to induce epitope-specific T cell responses but confers non-specific protective immunity in a malaria modelRole of attached lipid in immunogenicity of Borrelia burgdorferi OspAGeneration of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5)Memory cytolytic T-lymphocytes: induction, regulation and implications for vaccine design.Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro.Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination constructInduction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cellsIsolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentrationInduction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine.Modern lipid-, carbohydrate-, and peptide-based delivery systems for peptide, vaccine, and gene products.A purified recombinant lipopeptide as adjuvant for cancer immunotherapyMechanisms of action of adjuvantsSelf-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact.Skin-Specific Unsaturated Fatty Acids Boost the Staphylococcus aureus Innate Immune Response.Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccines.Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway.Solid-phase synthesis and application of double-fluorescent-labeled lipopeptides, containing a CTL-epitope from the measles fusion protein.A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-EThe effect of lipoylation on CD4 T-cell recognition of the 19,000 MW Mycobacterium tuberculosis antigen
P2860
Q24680097-A4DD65CB-8603-4B7D-882E-DE5414DDDA14Q27486078-84A5E0F4-08F2-4CAE-8276-69932B379D77Q28768428-4DC215B9-ACF9-4EE0-8E7F-3E1A51F2EE64Q33628862-578B2A37-DE4C-4A05-B5A5-AB126DFF1B02Q33756279-541EF35C-CC46-4444-8D72-105E55E9D97EQ33943139-551F9336-D8E3-4C6E-88B8-9A973D6466FEQ33956199-F541CB3B-4894-4FA5-AE76-787B3D1BAE46Q34004723-6BC9D146-53D2-4BA2-9EAE-4992707A72A9Q34102747-E6D1EE84-B4C1-4283-8744-B65B6C6875FCQ34195888-FF6003EB-0C05-40BC-B433-14B029983607Q34280941-C45106DD-ABBA-4DCC-BA18-37DD4DCD99C3Q34398787-7286FA6D-66D6-4FF5-AFC5-C78A18AFA784Q34520778-E58E4A17-6973-40F7-AEFE-4A4D044418AAQ34527878-C531391B-72AF-4613-914D-ED69B32F81FFQ35552591-A3E04ECF-2F1F-4C2D-966C-26A5DA02EA8CQ35848231-64A562F6-A447-4627-B066-31983DEE3EABQ36284560-CC5A962F-7933-460D-8154-831AEF2DE07CQ36377398-E848D869-DF24-4061-960D-A8E4C7873982Q36520832-E2EAEB6D-52D3-41C1-BB1C-DC6E85557DB2Q36616720-567E6E1C-CC8D-49EA-9079-242FFD853C23Q36650065-AAA31E0B-9557-4E8F-BEF3-8CCE0DA33034Q36862967-9553123A-7A0C-4CAA-A6CD-341F6CBA5026Q37213029-793DCBD5-657B-4D55-8EE1-B7AC87F85DC7Q37661001-4B110D19-61C2-47C3-BA6F-8FF6E4929CC2Q37668805-446EB0CF-B9B5-453C-87C1-775452EDA093Q38110539-88CDABF2-CEDC-492D-9F0F-F4BEFCE1A9ADQ38279548-4EA7C278-D8E8-41DA-9ED9-E30C16FB208FQ38824843-B43C0FC7-ECAC-4960-A230-273068F59592Q39143157-3ADB26E5-0779-42E3-B8AC-0EB48CF42DC0Q40054175-78485655-3F80-430F-A7E1-195B0A209A4EQ40381395-7F0FB2D2-0C8C-4F05-9D66-1533A661C82DQ40917793-E47FEBA4-457E-40B1-B1D1-046CEF9A9B29Q42603854-236DF574-B925-4131-A7D1-A2759CE4AE20Q57222956-87B8E21A-227A-46CD-8CAF-8CFAB15FD232
P2860
Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Efficiency of peptides and lip ...... us-specific cytotoxic T cells.
@en
Efficiency of peptides and lip ...... us-specific cytotoxic T cells.
@nl
type
label
Efficiency of peptides and lip ...... us-specific cytotoxic T cells.
@en
Efficiency of peptides and lip ...... us-specific cytotoxic T cells.
@nl
prefLabel
Efficiency of peptides and lip ...... us-specific cytotoxic T cells.
@en
Efficiency of peptides and lip ...... us-specific cytotoxic T cells.
@nl
P2093
P356
P1476
Efficiency of peptides and lip ...... us-specific cytotoxic T cells.
@en
P2093
P304
P356
10.1002/EJI.1830211102
P407
P577
1991-11-01T00:00:00Z